Charles River Laboratories CRL Debt Repayments
Debt Repayments at other companies
Other financials
Where this comes from
Reported directly by Charles River Laboratories in its filing.
Tagged under the XBRL concept us-gaap:RepaymentsOfLongTermDebtAndCapitalSecurities.
The official record: Charles River Laboratories’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Charles River Laboratories's debt repayments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Charles River Laboratories's debt repayments?
- Charles River Laboratories (CRL) reported debt repayments of $355.68M in Q1 2026.
- How has Charles River Laboratories's debt repayments changed year-over-year?
- Charles River Laboratories's debt repayments increased by 138.1% year-over-year, from $149.39M to $355.68M.
- What is the long-term trend for Charles River Laboratories's debt repayments?
- Over 4 years (2021 to 2025), Charles River Laboratories's debt repayments has grown at a -31.8% compound annual growth rate (CAGR), from $6.24B to $1.35B.
- What does debt repayments mean?
- Cash used to pay off debt obligations.
- How do you interpret debt repayments?
- Higher values indicate active debt reduction and improved balance sheet health, while lower values may suggest a preference for maintaining leverage or limited cash availability.
- How does debt repayments compare across companies?
- Commonly aligned with debt maturity schedules across the industry.